by emanuela.scacheri@demo112.axxiem.com | Oct 11, 2024 | 2024, Events, News
Nerviano Medical Sciences is excited to announce the participation in BIO-Europe 2024, Europe’s premier life sciences partnering event. – In-Person Event: November 4–6, 2024, Stockholm, Sweden – Digital Partnering: November 12–13, 2024 We look...
by nms-sync | Oct 9, 2024 | News
We are speaking at the 15th Annual WADC 2024 in San Diego .
partnering event in
San Diego ,
4 – 7 Nov. 2024
We look forward to your presence to explore future partnership opportunities.
* * * * *
Contact:
...
by emanuela.scacheri@demo112.axxiem.com | Oct 9, 2024 | 2024, News
We are pleased to announce the publication of our review article titled “Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting Agents” in Pharmaceuticals, as part of the Special Issue “Evaluation of the Antitumor...
by nms-sync | Sep 11, 2024 | News
NERVIANO, IT, September 11, 2024 – NMS Group S.p.A. (NMS Group), the largest oncological R&D company in Italy, announces today a change to its shareholding structure, leading to a restructured board of directors and statutory auditors. The Fondazione Regionale per...
by emanuela.scacheri@demo112.axxiem.com | Sep 9, 2024 | 2024, News
Turning the Impossible into Reality: A chemical astronaut harnesses blue light irradiation to activate Passerini products containing a Hantzsch ester, derived from what are considered “impossible aldehydes.” Be sure to check out the stunning artwork created by...
by nms-sync | Sep 5, 2024 | News
– NMS to receive in excess of $50 Million in upfront cash and milestone payments; total returns capped at a multiple of investment
– Financing proceeds will be used to advance NMS’ current pipeline and ADC platform
NERVIANO, Italy and...
Welcome and Check out our new motion picture!
Recent Comments